Hoyland, yes I agree with your comment“As others have pointed...

Hoyland, yes I agree with your comment

“As others have pointed out, BLT is not behaving like a company that is about to run out of money …...”

Several things suggest that Benitec and people who have joined the company of late do not expect the money to run out soon:

- appointing the CRO for the HCV program

- Dr David Suhy joining Benitec from Tacere following the Tacere acquisition

- Dr Mick Graham moving full time to Benitec as Chief Scientist

- appointment of Carl Stubbings as Chief Business Officer

- appointment of Dr Per Lindell as Strategic Business Advisor in the US

And we also have Director Mel Bridges upping his stake in Benitec on Dec 6th with the purchase of 1.42 million shares to take his total interest to 4.13 million shares plus approx 13 million options of various kinds. Would it be rational to do this if he expected BLT would soon be going to market to raise capital ? But would he be free, as a Director, to expand his stake knowing something was brewing that the rest of us didn't know about ?

So where is the money going to come from – and when ???